Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforaminal epidural autologous conditioned serum versus triamcinolone for unilateral lumbar radicular pain
IRCT20190513043580N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous conditioned serum, triamcinolone and lidocaine in lumbosacral radiculopathy and lumbodynia (LBP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pain intensity and Disability. Started Jul 2019; status: completed.
02
Drugs
autologous conditioned serumtriamcinolonelidocaine
03
Conditions
lumbosacral radiculopathylumbodynia (LBP)
Beyond the preview
Go deeper on IRCT20190513043580N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190513043580N1.